Global Custom Monoclonal Antibody Development Services Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI02260644

Publication Date:

February 21, 2025

Pages:

137

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Custom Monoclonal Antibody Development Services market size is predicted to grow from US$ 589 million in 2025 to US$ 817 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031.
Custom monoclonal antibody development services are specialized offerings provided by biotechnology companies or research institutions that involve a comprehensive process of creating monoclonal antibodies tailored to specific client requirements. Utilizing techniques like immunization of animals with chosen antigens, cell fusion, screening, and extensive characterization, these services aim to produce highly specific, homogeneous antibodies capable of recognizing unique targets, which are crucial for applications in areas such as biomedical research, diagnostics, and therapeutics.
United States market for Custom Monoclonal Antibody Development Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Custom Monoclonal Antibody Development Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Custom Monoclonal Antibody Development Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Custom Monoclonal Antibody Development Services players cover GenScript, Sino Biological, R&D Systems, Thermo Fisher Scientific Inc, CDI Labs, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淐ustom Monoclonal Antibody Development Services Industry Forecast鈥� looks at past sales and reviews total world Custom Monoclonal Antibody Development Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Custom Monoclonal Antibody Development Services sales for 2025 through 2031. With Custom Monoclonal Antibody Development Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Custom Monoclonal Antibody Development Services industry.
This Insight Report provides a comprehensive analysis of the global Custom Monoclonal Antibody Development Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Custom Monoclonal Antibody Development Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Custom Monoclonal Antibody Development Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Custom Monoclonal Antibody Development Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Custom Monoclonal Antibody Development Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Custom Monoclonal Antibody Development Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Based on the Host Animal
Based on the Technology Platform
Segmentation by Application:
Biomedical Research
Diagnostics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GenScript
Sino Biological
R&D Systems
Thermo Fisher Scientific Inc
CDI Labs
ProteoGenix
Bio-Techne
Eurogentec
BioGenes GmbH
BBI Solutions
Immunostep
Fortis Life Sciences
ProMab
OriGene
Biocompare
Precision Antibody

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Custom Monoclonal Antibody Development Services Market Size (2020-2031)
2.1.2 Custom Monoclonal Antibody Development Services Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Custom Monoclonal Antibody Development Services by Country/Region (2020, 2024 & 2031)
2.2 Custom Monoclonal Antibody Development Services Segment by Type
2.2.1 Based on the Host Animal
2.2.2 Based on the Technology Platform
2.3 Custom Monoclonal Antibody Development Services Market Size by Type
2.3.1 Custom Monoclonal Antibody Development Services Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Custom Monoclonal Antibody Development Services Market Size Market Share by Type (2020-2025)
2.4 Custom Monoclonal Antibody Development Services Segment by Application
2.4.1 Biomedical Research
2.4.2 Diagnostics
2.4.3 Others
2.5 Custom Monoclonal Antibody Development Services Market Size by Application
2.5.1 Custom Monoclonal Antibody Development Services Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Custom Monoclonal Antibody Development Services Market Size Market Share by Application (2020-2025)
3 Custom Monoclonal Antibody Development Services Market Size by Player
3.1 Custom Monoclonal Antibody Development Services Market Size Market Share by Player
3.1.1 Global Custom Monoclonal Antibody Development Services Revenue by Player (2020-2025)
3.1.2 Global Custom Monoclonal Antibody Development Services Revenue Market Share by Player (2020-2025)
3.2 Global Custom Monoclonal Antibody Development Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Custom Monoclonal Antibody Development Services by Region
4.1 Custom Monoclonal Antibody Development Services Market Size by Region (2020-2025)
4.2 Global Custom Monoclonal Antibody Development Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas Custom Monoclonal Antibody Development Services Market Size Growth (2020-2025)
4.4 APAC Custom Monoclonal Antibody Development Services Market Size Growth (2020-2025)
4.5 Europe Custom Monoclonal Antibody Development Services Market Size Growth (2020-2025)
4.6 Middle East & Africa Custom Monoclonal Antibody Development Services Market Size Growth (2020-2025)
5 Americas
5.1 Americas Custom Monoclonal Antibody Development Services Market Size by Country (2020-2025)
5.2 Americas Custom Monoclonal Antibody Development Services Market Size by Type (2020-2025)
5.3 Americas Custom Monoclonal Antibody Development Services Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Custom Monoclonal Antibody Development Services Market Size by Region (2020-2025)
6.2 APAC Custom Monoclonal Antibody Development Services Market Size by Type (2020-2025)
6.3 APAC Custom Monoclonal Antibody Development Services Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Custom Monoclonal Antibody Development Services Market Size by Country (2020-2025)
7.2 Europe Custom Monoclonal Antibody Development Services Market Size by Type (2020-2025)
7.3 Europe Custom Monoclonal Antibody Development Services Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Custom Monoclonal Antibody Development Services by Region (2020-2025)
8.2 Middle East & Africa Custom Monoclonal Antibody Development Services Market Size by Type (2020-2025)
8.3 Middle East & Africa Custom Monoclonal Antibody Development Services Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Custom Monoclonal Antibody Development Services Market Forecast
10.1 Global Custom Monoclonal Antibody Development Services Forecast by Region (2026-2031)
10.1.1 Global Custom Monoclonal Antibody Development Services Forecast by Region (2026-2031)
10.1.2 Americas Custom Monoclonal Antibody Development Services Forecast
10.1.3 APAC Custom Monoclonal Antibody Development Services Forecast
10.1.4 Europe Custom Monoclonal Antibody Development Services Forecast
10.1.5 Middle East & Africa Custom Monoclonal Antibody Development Services Forecast
10.2 Americas Custom Monoclonal Antibody Development Services Forecast by Country (2026-2031)
10.2.1 United States Market Custom Monoclonal Antibody Development Services Forecast
10.2.2 Canada Market Custom Monoclonal Antibody Development Services Forecast
10.2.3 Mexico Market Custom Monoclonal Antibody Development Services Forecast
10.2.4 Brazil Market Custom Monoclonal Antibody Development Services Forecast
10.3 APAC Custom Monoclonal Antibody Development Services Forecast by Region (2026-2031)
10.3.1 China Custom Monoclonal Antibody Development Services Market Forecast
10.3.2 Japan Market Custom Monoclonal Antibody Development Services Forecast
10.3.3 Korea Market Custom Monoclonal Antibody Development Services Forecast
10.3.4 Southeast Asia Market Custom Monoclonal Antibody Development Services Forecast
10.3.5 India Market Custom Monoclonal Antibody Development Services Forecast
10.3.6 Australia Market Custom Monoclonal Antibody Development Services Forecast
10.4 Europe Custom Monoclonal Antibody Development Services Forecast by Country (2026-2031)
10.4.1 Germany Market Custom Monoclonal Antibody Development Services Forecast
10.4.2 France Market Custom Monoclonal Antibody Development Services Forecast
10.4.3 UK Market Custom Monoclonal Antibody Development Services Forecast
10.4.4 Italy Market Custom Monoclonal Antibody Development Services Forecast
10.4.5 Russia Market Custom Monoclonal Antibody Development Services Forecast
10.5 Middle East & Africa Custom Monoclonal Antibody Development Services Forecast by Region (2026-2031)
10.5.1 Egypt Market Custom Monoclonal Antibody Development Services Forecast
10.5.2 South Africa Market Custom Monoclonal Antibody Development Services Forecast
10.5.3 Israel Market Custom Monoclonal Antibody Development Services Forecast
10.5.4 Turkey Market Custom Monoclonal Antibody Development Services Forecast
10.6 Global Custom Monoclonal Antibody Development Services Forecast by Type (2026-2031)
10.7 Global Custom Monoclonal Antibody Development Services Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Custom Monoclonal Antibody Development Services Forecast
11 Key Players Analysis
11.1 GenScript
11.1.1 GenScript Company Information
11.1.2 GenScript Custom Monoclonal Antibody Development Services Product Offered
11.1.3 GenScript Custom Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 GenScript Main Business Overview
11.1.5 GenScript Latest Developments
11.2 Sino Biological
11.2.1 Sino Biological Company Information
11.2.2 Sino Biological Custom Monoclonal Antibody Development Services Product Offered
11.2.3 Sino Biological Custom Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Sino Biological Main Business Overview
11.2.5 Sino Biological Latest Developments
11.3 R&D Systems
11.3.1 R&D Systems Company Information
11.3.2 R&D Systems Custom Monoclonal Antibody Development Services Product Offered
11.3.3 R&D Systems Custom Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 R&D Systems Main Business Overview
11.3.5 R&D Systems Latest Developments
11.4 Thermo Fisher Scientific Inc
11.4.1 Thermo Fisher Scientific Inc Company Information
11.4.2 Thermo Fisher Scientific Inc Custom Monoclonal Antibody Development Services Product Offered
11.4.3 Thermo Fisher Scientific Inc Custom Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Thermo Fisher Scientific Inc Main Business Overview
11.4.5 Thermo Fisher Scientific Inc Latest Developments
11.5 CDI Labs
11.5.1 CDI Labs Company Information
11.5.2 CDI Labs Custom Monoclonal Antibody Development Services Product Offered
11.5.3 CDI Labs Custom Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 CDI Labs Main Business Overview
11.5.5 CDI Labs Latest Developments
11.6 ProteoGenix
11.6.1 ProteoGenix Company Information
11.6.2 ProteoGenix Custom Monoclonal Antibody Development Services Product Offered
11.6.3 ProteoGenix Custom Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 ProteoGenix Main Business Overview
11.6.5 ProteoGenix Latest Developments
11.7 Bio-Techne
11.7.1 Bio-Techne Company Information
11.7.2 Bio-Techne Custom Monoclonal Antibody Development Services Product Offered
11.7.3 Bio-Techne Custom Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bio-Techne Main Business Overview
11.7.5 Bio-Techne Latest Developments
11.8 Eurogentec
11.8.1 Eurogentec Company Information
11.8.2 Eurogentec Custom Monoclonal Antibody Development Services Product Offered
11.8.3 Eurogentec Custom Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Eurogentec Main Business Overview
11.8.5 Eurogentec Latest Developments
11.9 BioGenes GmbH
11.9.1 BioGenes GmbH Company Information
11.9.2 BioGenes GmbH Custom Monoclonal Antibody Development Services Product Offered
11.9.3 BioGenes GmbH Custom Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 BioGenes GmbH Main Business Overview
11.9.5 BioGenes GmbH Latest Developments
11.10 BBI Solutions
11.10.1 BBI Solutions Company Information
11.10.2 BBI Solutions Custom Monoclonal Antibody Development Services Product Offered
11.10.3 BBI Solutions Custom Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 BBI Solutions Main Business Overview
11.10.5 BBI Solutions Latest Developments
11.11 Immunostep
11.11.1 Immunostep Company Information
11.11.2 Immunostep Custom Monoclonal Antibody Development Services Product Offered
11.11.3 Immunostep Custom Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Immunostep Main Business Overview
11.11.5 Immunostep Latest Developments
11.12 Fortis Life Sciences
11.12.1 Fortis Life Sciences Company Information
11.12.2 Fortis Life Sciences Custom Monoclonal Antibody Development Services Product Offered
11.12.3 Fortis Life Sciences Custom Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Fortis Life Sciences Main Business Overview
11.12.5 Fortis Life Sciences Latest Developments
11.13 ProMab
11.13.1 ProMab Company Information
11.13.2 ProMab Custom Monoclonal Antibody Development Services Product Offered
11.13.3 ProMab Custom Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 ProMab Main Business Overview
11.13.5 ProMab Latest Developments
11.14 OriGene
11.14.1 OriGene Company Information
11.14.2 OriGene Custom Monoclonal Antibody Development Services Product Offered
11.14.3 OriGene Custom Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 OriGene Main Business Overview
11.14.5 OriGene Latest Developments
11.15 Biocompare
11.15.1 Biocompare Company Information
11.15.2 Biocompare Custom Monoclonal Antibody Development Services Product Offered
11.15.3 Biocompare Custom Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Biocompare Main Business Overview
11.15.5 Biocompare Latest Developments
11.16 Precision Antibody
11.16.1 Precision Antibody Company Information
11.16.2 Precision Antibody Custom Monoclonal Antibody Development Services Product Offered
11.16.3 Precision Antibody Custom Monoclonal Antibody Development Services Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Precision Antibody Main Business Overview
11.16.5 Precision Antibody Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂